Evidence is emerging demonstrating an association between tiny crystal-like formations, known as Calcifying Nanoparticles (CNPs) and numerous health conditions affecting the heart, prostate, kidneys, joints, and other areas. CNPs, formerly known as nanobacteria, are comprised of calcium and phosphate and measure approximately 100 nanometers in size. CNPs have been identified in calcified plaque (soft tissue calcification) from numerous organs including the coronary arteries, prostate, ovaries, kidneys and skin.

The medical industry has long known that soft tissue calcification exists. In the past, this phenomenon was regarded as harmless. However, new research indicates that errant calcium crystals can not only harden areas in our soft tissues, they can also act as initiators of inflammation. Since cellular inflammation plays a critical role in many health challenges, stopping this inflammatory trigger can go a long way toward maintaining optimal health.

The good news is that we don’t have to live with soft tissue calcification. A recent study published in the International Journal of Pathophysiology suggests that with the right combination of ingredients, calcification seems to be reversible.**